Document Detail


Financing of health systems to achieve the health Millennium Development Goals in low-income countries.
MedLine Citation:
PMID:  20113826     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Concern that underfunded and weak health systems are impeding the achievement of the health Millennium Development Goals in low-income countries led to the creation of a High Level Taskforce on Innovative International Financing for Health Systems in September, 2008. This report summarises the key challenges faced by the Taskforce and its Working Groups. Working Group 1 examined the constraints to scaling up and costs. Challenges included: difficulty in generalisation because of scarce and context-specific health-systems knowledge; no consensus for optimum service-delivery approaches, leading to wide cost differences; no consensus for health benefits; difficulty in quantification of likely efficiency gains; and challenges in quantification of the financing gap owing to uncertainties about financial commitments for health. Working Group 2 reviewed the different innovative mechanisms for raising and channelling funds. Challenges included: variable definitions of innovative finance; small evidence base for many innovative finance mechanisms; insufficient experience in harmonisation of global health initiatives; and inadequate experience in use of international investments to improve maternal, newborn, and child health. The various mechanisms reviewed and finally recommended all had different characteristics, some focusing on specific problems and some on raising resources generally. Contentious issues included the potential role of the private sector, the rights-based approach to health, and the move to results-based aid. The challenges and disagreements that arose during the work of the Taskforce draw attention to the many issues facing decision makers in low-income countries. International donors and recipient governments should work together to improve the evidence base for strengthening health systems, increase long-term commitments, and improve accountability through transparent and inclusive national approaches.
Authors:
Robert Fryatt; Anne Mills; Anders Nordstrom
Related Documents :
19200796 - Exploring pluripotency with chemical genetics.
8277136 - Meeting holistic health needs through a religious organization: the congregation.
25170576 - Should they stay or should they go? leader duration and financial performance in local ...
10105716 - Visiting healthcare executives: more than just guests.
17199886 - The value of health care--a matter of discussion in germany.
25069626 - Interface, interaction and integration: how people with chronic disease in australia ma...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Lancet     Volume:  375     ISSN:  1474-547X     ISO Abbreviation:  Lancet     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-02-01     Completed Date:  2010-02-18     Revised Date:  2010-03-23    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  England    
Other Details:
Languages:  eng     Pagination:  419-26     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2010 Elsevier Ltd. All rights reserved.
Affiliation:
Health Systems and Services, World Health Organization, Geneva, Switzerland. bobfryatt@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Capital Financing / trends*
Delivery of Health Care / economics*,  organization & administration
Developing Countries
Goals*
Health Planning Councils / organization & administration
Health Policy / economics
Humans
International Cooperation
Organizational Innovation / economics*
United Nations
World Health
Comments/Corrections
Comment In:
Lancet. 2010 Mar 20;375(9719):983   [PMID:  20304243 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemot...
Next Document:  Distinct patterns of cytogenetic and clinical progression in chronic myeloproliferative neoplasms wi...